- $2.43bn
- $3.32bn
- $1.96bn
- 97
- 66
- 99
- 99
Annual income statement for Corecivic, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,905 | 1,863 | 1,845 | 1,897 | 1,962 |
Cost of Revenue | |||||
Gross Profit | 499 | 526 | 432 | 434 | 468 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,750 | 1,730 | 1,684 | 1,729 | 1,808 |
Operating Profit | 156 | 133 | 162 | 167 | 154 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 59.7 | 86.1 | 165 | 95.8 | 92 |
Provision for Income Taxes | |||||
Net Income After Taxes | 55.3 | -51.9 | 122 | 67.6 | 68.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 54.2 | -51.9 | 122 | 67.6 | 68.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 54.2 | -51.9 | 122 | 67.6 | 69.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.57 | 0.075 | 0.576 | 0.619 | 0.986 |